Cerenome (PSTV) Revenue (2011 - 2026)
Plus Therapeutics (PSTV) posted quarterly Revenue of $1.0 million for Q1 2026, down 2.93% year-over-year from $1.1 million in Q1 2025, and down 24.8% quarter-over-quarter from $1.4 million in Q4 2025.
Cerenome (PSTV) Revenue (2011 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has reported Revenue for 14 consecutive years, with $1.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Revenue fell 2.93% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $5.2 million (changed 0.46% YoY), while the FY2025 annual figure was $5.2 million, down 10.49% from the prior year.
- Revenue retreated to $1.0 million in Q1 2026 per PSTV's latest filing, from $1.4 million in the prior quarter.
- Across five years, Revenue topped out at $1.9 million in Q2 2023 and bottomed at $73000.0 in Q3 2022.
- Historically, Revenue has averaged $1.1 million across 5 years, with a median of $1.3 million in 2023.
- Annual changes were most pronounced in 2023 — Revenue soared 1598.63% — and 2025, when it sank 36.85%.
- Plus Therapeutics' Revenue stood at $127000.0 in 2022, then surged by 933.86% to $1.3 million in 2023, then grew by 7.54% to $1.4 million in 2024, then declined by 3.19% to $1.4 million in 2025, then decreased by 24.8% to $1.0 million in 2026.
- Business Quant data shows PSTV's Revenue at $1.0 million in Q1 2026, $1.4 million in Q4 2025, and $1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Cerenome | 28.07 Mn | 19.48 Mn | - | 411,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.03 Mn |
| Dec 31, 2025 | 1.37 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | 1.39 Mn |
| Mar 31, 2025 | 1.06 Mn |
| Dec 31, 2024 | 1.41 Mn |
| Sep 30, 2024 | 1.46 Mn |
| Jun 30, 2024 | 1.28 Mn |
| Mar 31, 2024 | 1.68 Mn |
| Dec 31, 2023 | 1.31 Mn |
| Sep 30, 2023 | 1.24 Mn |
| Jun 30, 2023 | 1.90 Mn |
| Mar 31, 2023 | 500,000.00 |
| Dec 31, 2022 | 127,000.00 |
| Sep 30, 2022 | 73,000.00 |
| Mar 31, 2019 | 703,000.00 |
| Dec 31, 2018 | 1.42 Mn |
| Sep 30, 2018 | 858,000.00 |
| Jun 30, 2018 | 660,000.00 |
| Mar 31, 2018 | 731,000.00 |